Perform Another (Advanced) Search

1. Clinical Trial Results by Drug Names
...the efficacy and safety of interferon alpha-2a (Roferon A injection) vs combination of oral amantadine (Viregyt K capsules) and interferon alpha-2a (Roferon A injection) in interferon- and amantadine-naïve patients with chronic hepatitis C. Fast Facts: Protocol number: M23156 Sponsor: Roche Hungary Ltd ...
View Page

2. Clinical Trial Results by Drug Names
...Randomized Study Evaluating the Efficacy and Safety of PEG-Interferon α-2a plus Ribavirin and Amantadine or plus Ribavirin in the Treatment of Patients with Chronic Hepatitis C Previously Non Responders ...
...multicenter, randomized study evaluating PEGASYS 180μg sc weekly plus ribavirin 1000/1200mg po qd and amantadine 200mg po qd (groups A and C) versus PEGASYS 180μg sc weekly plus ribavirin 1000 ...
View Page

3. Clinical Trial Results by Drug Names
...the efficacy and tolerability of pegylated interferon alfa (PEG-IFN) plus ribavirin with and without amantadine sulfate in patients with chronic hepatitis C and subtype 1 Fast Facts: Protocol number: M78023 ...
...and tolerability of peginterferon alfa-2a (40KD) (PEGASYS) plus oral ribavirin tablets with or without amantadine sulfate, in patients with chronic hepatitis C (CHC). After 48 weeks of treatment, there was ...
View Page

4.  Study Posting (4519) Trial #125330, Hepatitis C; Chronic, Yvoir, Belgium
...Trial Information A Study of PEGASYS (Peginterferon alfa-2a (40KD)) Plus Ribavirin, With or Without Amantadine, in Treatment-Naive or Relapsing Patients With Chronic Hepatitis C (CHC) Status: Completed Protocol Number ...
...Company Division: Pharmaceutical Official Scientific Title: A randomized, open-label study of the addition of amantadine to PEGASYS plus ribavirin on sustained virological response in patients with chronic hepatitis C viral ...
View Page

5.  Study Posting (4519) Trial #124740, Hepatitis C; Chronic, Verviers, Belgium
...Trial Information A Study of PEGASYS (Peginterferon alfa-2a (40KD)) Plus Ribavirin, With or Without Amantadine, in Treatment-Naive or Relapsing Patients With Chronic Hepatitis C (CHC) Status: Completed Protocol Number ...
...Company Division: Pharmaceutical Official Scientific Title: A randomized, open-label study of the addition of amantadine to PEGASYS plus ribavirin on sustained virological response in patients with chronic hepatitis C viral ...
View Page

6.  Study Posting (4519) Trial #124909, Hepatitis C; Chronic, Tournai, Belgium
...Trial Information A Study of PEGASYS (Peginterferon alfa-2a (40KD)) Plus Ribavirin, With or Without Amantadine, in Treatment-Naive or Relapsing Patients With Chronic Hepatitis C (CHC) Status: Completed Protocol Number ...
...Company Division: Pharmaceutical Official Scientific Title: A randomized, open-label study of the addition of amantadine to PEGASYS plus ribavirin on sustained virological response in patients with chronic hepatitis C viral ...
View Page

7.  Study Posting (4519) Trial #125329, Hepatitis C; Chronic, Seraing, Belgium
...Trial Information A Study of PEGASYS (Peginterferon alfa-2a (40KD)) Plus Ribavirin, With or Without Amantadine, in Treatment-Naive or Relapsing Patients With Chronic Hepatitis C (CHC) Status: Completed Protocol Number ...
...Company Division: Pharmaceutical Official Scientific Title: A randomized, open-label study of the addition of amantadine to PEGASYS plus ribavirin on sustained virological response in patients with chronic hepatitis C viral ...
View Page

8.  Study Posting (4519) Trial #124727, Hepatitis C; Chronic, Roeselare, Belgium
...Trial Information A Study of PEGASYS (Peginterferon alfa-2a (40KD)) Plus Ribavirin, With or Without Amantadine, in Treatment-Naive or Relapsing Patients With Chronic Hepatitis C (CHC) Status: Completed Protocol Number ...
...Company Division: Pharmaceutical Official Scientific Title: A randomized, open-label study of the addition of amantadine to PEGASYS plus ribavirin on sustained virological response in patients with chronic hepatitis C viral ...
View Page

9.  Study Posting (4519) Trial #124682, Hepatitis C; Chronic, Namur, Belgium
...Trial Information A Study of PEGASYS (Peginterferon alfa-2a (40KD)) Plus Ribavirin, With or Without Amantadine, in Treatment-Naive or Relapsing Patients With Chronic Hepatitis C (CHC) Status: Completed Protocol Number ...
...Company Division: Pharmaceutical Official Scientific Title: A randomized, open-label study of the addition of amantadine to PEGASYS plus ribavirin on sustained virological response in patients with chronic hepatitis C viral ...
View Page

10.  Study Posting (4519) Trial #124884, Hepatitis C; Chronic, Mons, Belgium
...Trial Information A Study of PEGASYS (Peginterferon alfa-2a (40KD)) Plus Ribavirin, With or Without Amantadine, in Treatment-Naive or Relapsing Patients With Chronic Hepatitis C (CHC) Status: Completed Protocol Number ...
...Company Division: Pharmaceutical Official Scientific Title: A randomized, open-label study of the addition of amantadine to PEGASYS plus ribavirin on sustained virological response in patients with chronic hepatitis C viral ...
View Page

11.  Study Posting (4519) Trial #122395, Hepatitis C; Chronic, Liege, Belgium
...Trial Information A Study of PEGASYS (Peginterferon alfa-2a (40KD)) Plus Ribavirin, With or Without Amantadine, in Treatment-Naive or Relapsing Patients With Chronic Hepatitis C (CHC) Status: Completed Protocol Number ...
...Company Division: Pharmaceutical Official Scientific Title: A randomized, open-label study of the addition of amantadine to PEGASYS plus ribavirin on sustained virological response in patients with chronic hepatitis C viral ...
View Page

12.  Study Posting (4519) Trial #122296, Hepatitis C; Chronic, Leuven, Belgium
...Trial Information A Study of PEGASYS (Peginterferon alfa-2a (40KD)) Plus Ribavirin, With or Without Amantadine, in Treatment-Naive or Relapsing Patients With Chronic Hepatitis C (CHC) Status: Completed Protocol Number ...
...Company Division: Pharmaceutical Official Scientific Title: A randomized, open-label study of the addition of amantadine to PEGASYS plus ribavirin on sustained virological response in patients with chronic hepatitis C viral ...
View Page

13.  Study Posting (4519) Trial #124670, Hepatitis C; Chronic, Kortrijk, Belgium
...Trial Information A Study of PEGASYS (Peginterferon alfa-2a (40KD)) Plus Ribavirin, With or Without Amantadine, in Treatment-Naive or Relapsing Patients With Chronic Hepatitis C (CHC) Status: Completed Protocol Number ...
...Company Division: Pharmaceutical Official Scientific Title: A randomized, open-label study of the addition of amantadine to PEGASYS plus ribavirin on sustained virological response in patients with chronic hepatitis C viral ...
View Page

14.  Study Posting (4519) Trial #125328, Hepatitis C; Chronic, Huy, Belgium
...Trial Information A Study of PEGASYS (Peginterferon alfa-2a (40KD)) Plus Ribavirin, With or Without Amantadine, in Treatment-Naive or Relapsing Patients With Chronic Hepatitis C (CHC) Status: Completed Protocol Number ...
...Company Division: Pharmaceutical Official Scientific Title: A randomized, open-label study of the addition of amantadine to PEGASYS plus ribavirin on sustained virological response in patients with chronic hepatitis C viral ...
View Page

15.  Study Posting (4519) Trial #125327, Hepatitis C; Chronic, Gilly, Belgium
...Trial Information A Study of PEGASYS (Peginterferon alfa-2a (40KD)) Plus Ribavirin, With or Without Amantadine, in Treatment-Naive or Relapsing Patients With Chronic Hepatitis C (CHC) Status: Completed Protocol Number ...
...Company Division: Pharmaceutical Official Scientific Title: A randomized, open-label study of the addition of amantadine to PEGASYS plus ribavirin on sustained virological response in patients with chronic hepatitis C viral ...
View Page

16.  Study Posting (4519) Trial #125624, Hepatitis C; Chronic, Gent, Belgium
...Trial Information A Study of PEGASYS (Peginterferon alfa-2a (40KD)) Plus Ribavirin, With or Without Amantadine, in Treatment-Naive or Relapsing Patients With Chronic Hepatitis C (CHC) Status: Completed Protocol Number ...
...Company Division: Pharmaceutical Official Scientific Title: A randomized, open-label study of the addition of amantadine to PEGASYS plus ribavirin on sustained virological response in patients with chronic hepatitis C viral ...
View Page

17.  Study Posting (4519) Trial #122295, Hepatitis C; Chronic, Genk, Belgium
...Trial Information A Study of PEGASYS (Peginterferon alfa-2a (40KD)) Plus Ribavirin, With or Without Amantadine, in Treatment-Naive or Relapsing Patients With Chronic Hepatitis C (CHC) Status: Completed Protocol Number ...
...Company Division: Pharmaceutical Official Scientific Title: A randomized, open-label study of the addition of amantadine to PEGASYS plus ribavirin on sustained virological response in patients with chronic hepatitis C viral ...
View Page

18.  Study Posting (4519) Trial #124130, Hepatitis C; Chronic, Edegem, Belgium
...Trial Information A Study of PEGASYS (Peginterferon alfa-2a (40KD)) Plus Ribavirin, With or Without Amantadine, in Treatment-Naive or Relapsing Patients With Chronic Hepatitis C (CHC) Status: Completed Protocol Number ...
...Company Division: Pharmaceutical Official Scientific Title: A randomized, open-label study of the addition of amantadine to PEGASYS plus ribavirin on sustained virological response in patients with chronic hepatitis C viral ...
View Page

19.  Study Posting (4519) Trial #124648, Hepatitis C; Chronic, Charleroi, Belgium
...Trial Information A Study of PEGASYS (Peginterferon alfa-2a (40KD)) Plus Ribavirin, With or Without Amantadine, in Treatment-Naive or Relapsing Patients With Chronic Hepatitis C (CHC) Status: Completed Protocol Number ...
...Company Division: Pharmaceutical Official Scientific Title: A randomized, open-label study of the addition of amantadine to PEGASYS plus ribavirin on sustained virological response in patients with chronic hepatitis C viral ...
View Page

20.  Study Posting (4519) Trial #125606, Hepatitis C; Chronic, Bruxelles, Belgium
...Trial Information A Study of PEGASYS (Peginterferon alfa-2a (40KD)) Plus Ribavirin, With or Without Amantadine, in Treatment-Naive or Relapsing Patients With Chronic Hepatitis C (CHC) Status: Completed Protocol Number ...
...Company Division: Pharmaceutical Official Scientific Title: A randomized, open-label study of the addition of amantadine to PEGASYS plus ribavirin on sustained virological response in patients with chronic hepatitis C viral ...
View Page